NASDAQ:MOTS

Motus GI Stock Forecast, Price & News

$0.76
+0.01 (+1.34 %)
(As of 09/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.73
$0.76
50-Day Range
$0.73
$1.03
52-Week Range
$0.68
$2.74
Volume295,379 shs
Average Volume2.71 million shs
Market Capitalization$36.60 million
P/E RatioN/A
Dividend YieldN/A
Beta2.58
30 days | 90 days | 365 days | Advanced Chart
Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.


Motus GI logo

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in September, 2016 and is headquartered in Fort Lauderdale, FL.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.73 out of 5 stars

Medical Sector

843rd out of 1,352 stocks

Surgical & Medical Instruments Industry

87th out of 123 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Motus GI (NASDAQ:MOTS) Frequently Asked Questions

Is Motus GI a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Motus GI stock.
View analyst ratings for Motus GI
or view top-rated stocks.

What stocks does MarketBeat like better than Motus GI?

Wall Street analysts have given Motus GI a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Motus GI wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Motus GI's next earnings date?

Motus GI is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Motus GI
.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its earnings results on Thursday, August, 12th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.11) by $0.01. The company earned $0.10 million during the quarter, compared to the consensus estimate of $0.08 million. Motus GI had a negative trailing twelve-month return on equity of 73.19% and a negative net margin of 8,058.18%.
View Motus GI's earnings history
.

How has Motus GI's stock price been impacted by Coronavirus (COVID-19)?

Motus GI's stock was trading at $1.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MOTS stock has decreased by 27.0% and is now trading at $0.7587.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for MOTS?

3 Wall Street analysts have issued 1 year target prices for Motus GI's stock. Their forecasts range from $1.50 to $2.05. On average, they anticipate Motus GI's share price to reach $1.85 in the next twelve months. This suggests a possible upside of 143.8% from the stock's current price.
View analysts' price targets for Motus GI
or view top-rated stocks among Wall Street analysts.

Who are Motus GI's key executives?

Motus GI's management team includes the following people:
  • Timothy P. Moran, Chief Executive Officer & Director
  • Mark Pomeranz, President, Chief Operating Officer & Director
  • Andrew L. Taylor, Chief Financial Officer
  • Ravit Ram, Vice President-Operations & Site Manager Israel
  • Jeff Hutchison, Vice President-U.S. Sales & Commercial Operations

Who are some of Motus GI's key competitors?

What other stocks do shareholders of Motus GI own?

When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Who are Motus GI's major shareholders?

Motus GI's stock is owned by a variety of retail and institutional investors. Top institutional investors include Oracle Investment Management Inc. (7.90%), Geode Capital Management LLC (0.71%), Renaissance Technologies LLC (0.35%), State Street Corp (0.17%), Morgan Stanley (0.11%) and Morgan Stanley (0.11%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Gary E Jacobs, Larry N Feinberg, Perceptive Advisors Llc and Timothy P Moran.
View institutional ownership trends for Motus GI
.

Which major investors are selling Motus GI stock?

MOTS stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Oracle Investment Management Inc., and Advisor Group Holdings Inc.. Company insiders that have sold Motus GI company stock in the last year include Larry N Feinberg, and Perceptive Advisors Llc.
View insider buying and selling activity for Motus GI
or view top insider-selling stocks.

Which major investors are buying Motus GI stock?

MOTS stock was bought by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, State Street Corp, Citadel Advisors LLC, Morgan Stanley, and Morgan Stanley. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Gary E Jacobs, and Timothy P Moran.
View insider buying and selling activity for Motus GI
or or view top insider-buying stocks.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $0.76.

How much money does Motus GI make?

Motus GI has a market capitalization of $36.60 million and generates $100,000.00 in revenue each year. The company earns $-19,260,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

How many employees does Motus GI have?

Motus GI employs 24 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is www.motusgi.com.

Where are Motus GI's headquarters?

Motus GI is headquartered at 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at (954) 541-8000 or via email at [email protected]


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.